Evaluate and treat patients with BRAF-mutated primary brain tumors.
The Johns Hopkins BRAF Brain Tumor Center aims to help patients with brain tumors that originated in the brain (primary brain tumors) that have a BRAF gene mutation. Our multispecialty team includes experts across neurosurgery and the Johns Hopkins Kimmel Cancer Center who provide patient care and conduct research to improve outcomes for patients with these rare tumors.
What We Do
Explore the role of new pathway inhibitors that might help treat these patients.
Partner with our basic science colleagues to discover mechanisms of resistance, clinically relevant targets and new pathway-specific drugs.
BRAF Brain Tumor Specialists
Christie Adams, PA-C
Physician Assistant working with Chetan Bettegowda, M.D., Ph.D.
Jill Anderson, PA-C
Physician Assistant Manager working with Henry Brem, M.D.
Ashley Kang, PA-C
Physician Assistant working with Debraj Mukherjee, M.D., M.P.H.
Carla Scott, PA-C
Senior Physician Assistant working with Chris Jackson, M.D., and Judy Huang, M.D.